Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Vaccines market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
GSK
J&J(Crucell)
Pfizer
Sanofi
MedImmune LLC
Merck
Tiantan
CSL
Novartis(GSK)
China National Biotec
Hualan
Jintan
Kangtai
Hissen
By Types:
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
By Applications:
Cholera
Hepatitis B
Diphtheria
Tetanus
Measles vaccine
Hepatitis A
Live attenuated influenza vaccine
Polio vaccine
Rabies vaccine
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Vaccines Revenue
1.5 Market Analysis by Type
1.5.1 Global Vaccines Market Size Growth Rate by Type: 2021 VS 2027
1.5.2 Recombinant Vaccines
1.5.3 Viral Vaccines
1.5.4 Polysaccharide Vaccines
1.5.5 Others
1.6 Market by Application
1.6.1 Global Vaccines Market Share by Application: 2022-2027
1.6.2 Cholera
1.6.3 Hepatitis B
1.6.4 Diphtheria
1.6.5 Tetanus
1.6.6 Measles vaccine
1.6.7 Hepatitis A
1.6.8 Live attenuated influenza vaccine
1.6.9 Polio vaccine
1.6.10 Rabies vaccine
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Vaccines Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter’s Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Vaccines Market Players Profiles
3.1 GSK
3.1.1 GSK Company Profile
3.1.2 GSK Vaccines Product Specification
3.1.3 GSK Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.2 J&J(Crucell)
3.2.1 J&J(Crucell) Company Profile
3.2.2 J&J(Crucell) Vaccines Product Specification
3.2.3 J&J(Crucell) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.3 Pfizer
3.3.1 Pfizer Company Profile
3.3.2 Pfizer Vaccines Product Specification
3.3.3 Pfizer Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 Sanofi
3.4.1 Sanofi Company Profile
3.4.2 Sanofi Vaccines Product Specification
3.4.3 Sanofi Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 MedImmune LLC
3.5.1 MedImmune LLC Company Profile
3.5.2 MedImmune LLC Vaccines Product Specification
3.5.3 MedImmune LLC Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 Merck
3.6.1 Merck Company Profile
3.6.2 Merck Vaccines Product Specification
3.6.3 Merck Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Tiantan
3.7.1 Tiantan Company Profile
3.7.2 Tiantan Vaccines Product Specification
3.7.3 Tiantan Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 CSL
3.8.1 CSL Company Profile
3.8.2 CSL Vaccines Product Specification
3.8.3 CSL Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Novartis(GSK)
3.9.1 Novartis(GSK) Company Profile
3.9.2 Novartis(GSK) Vaccines Product Specification
3.9.3 Novartis(GSK) Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 China National Biotec
3.10.1 China National Biotec Company Profile
3.10.2 China National Biotec Vaccines Product Specification
3.10.3 China National Biotec Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 Hualan
3.11.1 Hualan Company Profile
3.11.2 Hualan Vaccines Product Specification
3.11.3 Hualan Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Jintan
3.12.1 Jintan Company Profile
3.12.2 Jintan Vaccines Product Specification
3.12.3 Jintan Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.13 Kangtai
3.13.1 Kangtai Company Profile
3.13.2 Kangtai Vaccines Product Specification
3.13.3 Kangtai Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.14 Hissen
3.14.1 Hissen Company Profile
3.14.2 Hissen Vaccines Product Specification
3.14.3 Hissen Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Vaccines Market Competition by Market Players
4.1 Global Vaccines Production Capacity Market Share by Market Players (2016-2021)
4.2 Global Vaccines Revenue Market Share by Market Players (2016-2021)
4.3 Global Vaccines Average Price by Market Players (2016-2021)
5 Global Vaccines Production by Regions (2016-2021)
5.1 North America
5.1.1 North America Vaccines Market Size (2016-2021)
5.1.2 Vaccines Key Players in North America (2016-2021)
5.1.3 North America Vaccines Market Size by Type (2016-2021)
5.1.4 North America Vaccines Market Size by Application (2016-2021)
5.2 East Asia
5.2.1 East Asia Vaccines Market Size (2016-2021)
5.2.2 Vaccines Key Players in East Asia (2016-2021)
5.2.3 East Asia Vaccines Market Size by Type (2016-2021)
5.2.4 East Asia Vaccines Market Size by Application (2016-2021)
5.3 Europe
5.3.1 Europe Vaccines Market Size (2016-2021)
5.3.2 Vaccines Key Players in Europe (2016-2021)
5.3.3 Europe Vaccines Market Size by Type (2016-2021)
5.3.4 Europe Vaccines Market Size by Application (2016-2021)
5.4 South Asia
5.4.1 South Asia Vaccines Market Size (2016-2021)
5.4.2 Vaccines Key Players in South Asia (2016-2021)
5.4.3 South Asia Vaccines Market Size by Type (2016-2021)
5.4.4 South Asia Vaccines Market Size by Application (2016-2021)
5.5 Southeast Asia
5.5.1 Southeast Asia Vaccines Market Size (2016-2021)
5.5.2 Vaccines Key Players in Southeast Asia (2016-2021)
5.5.3 Southeast Asia Vaccines Market Size by Type (2016-2021)
5.5.4 Southeast Asia Vaccines Market Size by Application (2016-2021)
5.6 Middle East
5.6.1 Middle East Vaccines Market Size (2016-2021)
5.6.2 Vaccines Key Players in Middle East (2016-2021)
5.6.3 Middle East Vaccines Market Size by Type (2016-2021)
5.6.4 Middle East Vaccines Market Size by Application (2016-2021)
5.7 Africa
5.7.1 Africa Vaccines Market Size (2016-2021)
5.7.2 Vaccines Key Players in Africa (2016-2021)
5.7.3 Africa Vaccines Market Size by Type (2016-2021)
5.7.4 Africa Vaccines Market Size by Application (2016-2021)
5.8 Oceania
5.8.1 Oceania Vaccines Market Size (2016-2021)
5.8.2 Vaccines Key Players in Oceania (2016-2021)
5.8.3 Oceania Vaccines Market Size by Type (2016-2021)
5.8.4 Oceania Vaccines Market Size by Application (2016-2021)
5.9 South America
5.9.1 South America Vaccines Market Size (2016-2021)
5.9.2 Vaccines Key Players in South America (2016-2021)
5.9.3 South America Vaccines Market Size by Type (2016-2021)
5.9.4 South America Vaccines Market Size by Application (2016-2021)
5.10 Rest of the World
5.10.1 Rest of the World Vaccines Market Size (2016-2021)
5.10.2 Vaccines Key Players in Rest of the World (2016-2021)
5.10.3 Rest of the World Vaccines Market Size by Type (2016-2021)
5.10.4 Rest of the World Vaccines Market Size by Application (2016-2021)
6 Global Vaccines Consumption by Region (2016-2021)
6.1 North America
6.1.1 North America Vaccines Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Vaccines Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Vaccines Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Vaccines Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Vaccines Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Vaccines Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Vaccines Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Vaccines Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Vaccines Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Vaccines Consumption by Countries
7 Global Vaccines Production Forecast by Regions (2022-2027)
7.1 Global Forecasted Production of Vaccines (2022-2027)
7.2 Global Forecasted Revenue of Vaccines (2022-2027)
7.3 Global Forecasted Price of Vaccines (2022-2027)
7.4 Global Forecasted Production of Vaccines by Region (2022-2027)
7.4.1 North America Vaccines Production, Revenue Forecast (2022-2027)
7.4.2 East Asia Vaccines Production, Revenue Forecast (2022-2027)
7.4.3 Europe Vaccines Production, Revenue Forecast (2022-2027)
7.4.4 South Asia Vaccines Production, Revenue Forecast (2022-2027)
7.4.5 Southeast Asia Vaccines Production, Revenue Forecast (2022-2027)
7.4.6 Middle East Vaccines Production, Revenue Forecast (2022-2027)
7.4.7 Africa Vaccines Production, Revenue Forecast (2022-2027)
7.4.8 Oceania Vaccines Production, Revenue Forecast (2022-2027)
7.4.9 South America Vaccines Production, Revenue Forecast (2022-2027)
7.4.10 Rest of the World Vaccines Production, Revenue Forecast (2022-2027)
7.5 Forecast by Type and by Application (2022-2027)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
7.5.2 Global Forecasted Consumption of Vaccines by Application (2022-2027)
8 Global Vaccines Consumption Forecast by Regions (2022-2027)
8.1 North America Forecasted Consumption of Vaccines by Country
8.2 East Asia Market Forecasted Consumption of Vaccines by Country
8.3 Europe Market Forecasted Consumption of Vaccines by Countriy
8.4 South Asia Forecasted Consumption of Vaccines by Country
8.5 Southeast Asia Forecasted Consumption of Vaccines by Country
8.6 Middle East Forecasted Consumption of Vaccines by Country
8.7 Africa Forecasted Consumption of Vaccines by Country
8.8 Oceania Forecasted Consumption of Vaccines by Country
8.9 South America Forecasted Consumption of Vaccines by Country
8.10 Rest of the world Forecasted Consumption of Vaccines by Country
9 Global Vaccines Sales by Type (2016-2027)
9.1 Global Vaccines Historic Market Size by Type (2016-2021)
9.2 Global Vaccines Forecasted Market Size by Type (2022-2027)
10 Global Vaccines Consumption by Application (2016-2027)
10.1 Global Vaccines Historic Market Size by Application (2016-2021)
10.2 Global Vaccines Forecasted Market Size by Application (2022-2027)
11 Global Vaccines Manufacturing Cost Analysis
11.1 Vaccines Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Vaccines
12 Global Vaccines Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Vaccines Distributors List
12.3 Vaccines Customers
12.4 Vaccines Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer
Research Methodology:
Vaccines Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|